An international, multicenter, placebo-controlled trial of paroxetine in adolescents with major depressive disorder

Journal of Child and Adolescent Psychopharmacology

Volumn 16, Issue 1-2, 2006, Pages 59-75

  Berard, Ray ^a,e   Fong, Regan ^b   Carpenter, David J ^b   Thomason, Christine ^c   Wilkinson, Christel ^d  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b GLAXOSMITHKLINE   (United States)

^c i3 Research   (United States)

^d GLAXOSMITHKLINE   (United Kingdom)

^e NONE   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; PAROXETINE; PLACEBO;

ADOLESCENT; ANOREXIA; ARTICLE; ASTHENIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; INFECTION; KIDDIE SCHEDULE FOR AFFECTIVE DISORDER AND SCHIZOPHRENIA FOR SCHOOL AGE CHILDREN DEPRESSION SUBSCALE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MULTICENTER STUDY; NAUSEA; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SOMNOLENCE; SUICIDAL BEHAVIOR;

ADOLESCENT; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTERNATIONALITY; LOGISTIC MODELS; MALE; PAROXETINE; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD;

EID: 33645822523     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2006.16.59     Document Type: Article

References (24)

1. American College of Neuropsychopharmacology: Executive summary: Preliminary report of the task force on SSRIs and suicide behaviour in youth. Online document at www.acnp.org/exec_summary.pdf/ Accessed on June 20, 2004.
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (DSM-IV). Washington, DC: American Psychiatric Association; 1994.
3. Beck AT, Rush AJ, Shaw BF, Emery G: Cognitive Therapy of Depression. New York, Guilford Press, 1979.
4. Birmaher B, Ryan ND, Williamson DE, Brent DA, Kaufman J, Dahl RE, Perel J, Nelson B: Childhood and adolescent depression: A review of the past 10 years. Part I. J Am Acad Child Adolesc Psychiatry 35:1427-1439, 1996.
5. Brent DA, Holder D, Kolko D, Birmaher B, Baugher M, Roth C, Iyengar S, Johnson BA: A clinical psychotherapy trial for adolescent depression comparing cognitive, family, and supportive therapy. Arch Gen Psychiatry 54:877-885, 1997.
6. Costello EJ, Angold A: Scales to assess child and adolescent depression: Checklists, screens, and nets. J Am Acad Child Adolesc Psychiatry 27:726-737, 1988.
7. Fong R, Lipschitz A, Carpenter D, Wetherhold E, Krulewicz S, Perera P: Suicidality in clinical trials: Using multiple search strategies. Washington (DC), American Academy of Child and Adolescent Psychiatry (AACAP) 51st Annual Meeting, 2004 [abstract].
8. GlaxoSmithKline: Paroxetine and Pediatric and Adolescent Clinical Trial Data. Online document at: www.gsk.com/media/paroxetine.htm/ Accessed on December 15, 2004.
9. Goodyer IM, Herbery J, Secher SM, Pearson J: Short-term outcome of major depression: I. Comorbidity and severity at presentation as predictors of persistent disorder. J Am Acad Child Adolesc Psychiatry 36:179-187, 1997.
10. Grunbaum JA, Kann L, Kinchen SA, Williams B, Ross JG, Lowry R, Kolbe L: Youth risk behavior surveillance - United States, 2001. MMWR CDC Surveill Summ 51:1-62, 2002.
11. Guy W: CGI global impressions. In: ECDEU Assessment Manual for Psychopharmacology - Revised. Washington (DC), US Department of Health, Education and Welfare, 1976.
12. Jonas J: Citalopram and escitalopram pediatric safety data. Presented at PDA Advisory Committee Meeting on September 13, 2004. Online document at: www.fda.gov/ohrms/dockets/ac/04/slides/2004-4065S1_10_Forest-Laboratories.ppt/ Accessed on September 24, 2004.
13. Jureidini JN, Doecke CJ, Mansfield PR, Haby MM, Menkes DB, Tonkin AL: Efficacy and safety of antidepressants for children and adolescents. BMJ 328:879-883, 2004.
14. Kaufman J, Birmaher B, Brent D, Rao U, Ryan N: Diagnostic interview: Kiddie-Sads-present and lifetime version (K-SADS-PL). 1996. Online document at: www.wpic.pitt.edu\ksads/ Accessed on September 2, 2004.
15. Keller MB, Ryan ND, Strober M, Klein RG, Kutcher SP, Birmaher B, Hagino OR, Koplewicz H, Carlson GA, Clarke GN, Emslie GJ, Feinberg D, Geller B, Kusumakar V, Papatheodorou G, Sack WH, Sweeney M, Wagner KD, Weller EB, Winters NC, Oakes R, McCafferty JP: Efficacy of paroxetine in the treatment of adolescent major depression: A randomized, controlled trial. J Am Acad Child Adolesc Psychiatry 40:762-772, 2001.
16. Kovacs M, Feinberg TL, Crouse-Novak M, Paulaiskas SL, Pollock M, Finkelstein R: Depressive disorders in childhood. Arch Gen Psychiatry 41:643-649, 1984.
17. Lewinsohn PM, Clarke GN, Seeley JR, Rohde P: Major depression in community adolescents: Age at onset, episode duration, and time to recurrence. J Am Acad Child Adolesc Psychiatry 33:809-818, 1994.
18. Laughren, T: Background on suicidality associated with antidepressant drug treatment. Memorandum, January 5, 2004. Online document at: www.fda.gov/ohrms/dockets/ac/04/briefing/4006B1_03_Background%20Memo%2001-05-04. pdf/ Accessed on September 2, 2004.
19. Montgomery SA, Åsberg M: A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382-389, 1979.
20. Shaffer D, Gould MS, Brasic J, Ambrosini P, Fisher P, Bird H, Aluwahlia S: A children's global assessment scale (CGAS). Arch Gen Psychiatry 40:1228-1231, 1983.
21. U.K. Department of Health Advisory. Online document at: www.mhra.gov.uk/news/2003/seroxat10603.pdf/ Accessed on December 10, 2004.
22. U.S. Food and Drug Administration: Public Health Advisory on Suicidality in Children and Adolescents Being Treated With Antidepressant Medications, October 15, 2004. Online document at: www.fda.gov/cder/drug/antidepressants/ SSRIPHA200410.htm/ Accessed on April 12, 2005.
23. Wagner KD, Ambrosini P, Rynn M, Wohlberg C, Yang R, Greenbaum MS, Childress A, Donnelly C, Deas D; Sertraline Pediatric Depression Study Group: Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: Two randomized, controlled trials. JAMA 290(8):1033-1041, 2003.
24. Whittington CJ, Kendall T, Fonagy P, Cottrell D, Cotgrove A, Boddington E: Selective serotonin reuptake inhibitors in childhood depression: Systematic review of published versus unpublished data. Lancet 363:1341-1345, 2004.